3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
12
Rectal Neoplasms
9
Glioblastoma
9
Esophageal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Colonic Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma of Lung
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Melanoma
2
Glioma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Wilms Tumor
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
Surgical Procedures, Operative
×
Clear all
No trials found.